Indexed in Journament

cancer

ISSN 1097-0142· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
41.9/100
Journament Score
#4,168
Journament Rank
32
Articles Indexed

About This Journal

Short Name cancer
Abbreviated Name cancer
ISSN 1097-0142
URL http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142

Indexings

scopus ncbi ulakbim sci

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (32)

2019
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
Johns, Shelley A;Stutz, Patrick V;Talib, Tasneem L;Cohee, Andrea A;Beck-Coon, Kathleen A;Brown, Linda F;Wilhelm, Laura R;Monahan, Patrick O;LaPradd, Michelle L;Champion, Victoria L;Miller, Kathy D;Giesler, R Brian;
510 views DOI Abstract
2018
Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
Gupta, Avni;Sonis, Stephen T;Schneider, Eric B;Villa, Alessandro;
Vol. 124 , No. 4 , pp. 760-768
402 views DOI Abstract
2019
Utilization pattern and service settings of palliative care for patients with metastatic non-small-cell lung cancer.
Huo, Jinhai;Hong, Young-Rock;Turner, Kea;Bian, Jiang;Grewal, Reetu;Wilkie, Diana J;
400 views DOI Abstract
2006
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions
Safdar A;Rodriguez GH;Lichtiger B;Dickey BF;Kontoyiannis DP;Freireich EJ;Shpall EJ;Raad II;Kantarjian HM;Champlin RE;;
Vol. 106 , No. 12 , pp. -
389 views Abstract
2020
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.
Li, Ang;Carlson, Josh J;Kuderer, Nicole M;Schaefer, Jordan K;Li, Shan;Garcia, David A;Khorana, Alok A;Carrier, Marc;Lyman, Gary H;
385 views DOI Abstract
2019
Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.
Mullins, Megan A;Peres, Lauren C;Alberg, Anthony J;Bandera, Elisa V;Barnholtz-Sloan, Jill S;Bondy, Melissa L;Funkhouser, Ellen;Moorman, Patricia G;Peters, Edward S;Terry, Paul D;Schwartz, Ann G;Lawson, Andrew B;Schildkraut, Joellen M;Cote, Michele L;
383 views DOI Abstract
2019
Physicians' perspectives on medication adherence and health promotion among cancer survivors.
Stump, Tammy K;Robinson, June K;Yanez, Betina;Penedo, Frank;Ezeofor, Adaeze;Kircher, Sheetal;Spring, Bonnie;
382 views DOI Abstract
2010
Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer
Chadha, M.
Vol. 116 , pp. 2132-2139
379 views DOI
2004
Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001)
Safdar A;Singhal S;Mehta J;;
Vol. 100 , No. 11 , pp. -
366 views Abstract
2000
Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors
Kristen N. Ganjoo,Karen M. Rieger,Kenneth A. Kesler,Matt Sharma,Douglas K. Heilman M.S.,Lawrence H. Einhorn M.D.;Kristen N. Ganjoo;Karen M. Rieger;Kenneth A. Kesler;Matt Sharma;Douglas K. Heilman M.S.;Lawrence H. Einhorn M.D.;
Vol. 88 , No. 5 , pp. 1051-1056
356 views DOI Abstract
2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Seiwert, Tanguy Y;Kochanny, Sara;Wood, Kevin;Worden, Francis P;Adkins, Douglas;Wade, James L;Sleckman, Bethany G;Anderson, Daniel;Brisson, Ryan J;Karrison, Theodore;Stadler, Walter M;Vokes, Everett E;
296 views DOI Abstract
2020
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma.
, ;
273 views DOI Abstract
2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Pal, Sumanta K;Bajorin, Dean;Dizman, Nazli;Hoffman-Censits, Jean;Quinn, David I;Petrylak, Daniel P;Galsky, Matthew D;Vaishampayan, Ulka;De Giorgi, Ugo;Gupta, Sumati;Burris, Howard A;Soifer, Harris S;Li, Gary;Wang, Hao;Dambkowski, Carl L;Moran, Susan;Daneshmand, Siamak;Rosenberg, Jonathan E;
234 views DOI Abstract
2020
Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors
Ramirez, A.
Vol. 126 , pp. 1112-1123
254 views DOI
2020
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
Yadav, S.
Vol. 126 , pp. 26-36
211 views DOI
2020
Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
Zhang, Hongjing;Qian, Guoqing;Zong, Dan;Fan, Songqing;Owonikoko, Taofeek K;Ramalingam, Suresh S;Sun, Shi-Yong;
338 views DOI Abstract
2020
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.
Li, Ang;Carlson, Josh J;Kuderer, Nicole M;Schaefer, Jordan K;Li, Shan;Garcia, David A;Khorana, Alok A;Carrier, Marc;Lyman, Gary H;
385 views DOI Abstract
2020
Physician and facility drivers of spending variation in locoregional prostate cancer.
Rodin, Danielle;Chien, Alyna T;Ellimoottil, Chad;Nguyen, Paul L;Kakani, Pragya;Mossanen, Matthew;Rosenthal, Meredith;Landrum, Mary Beth;Sinaiko, Anna D;
283 views DOI Abstract
2020
The efficacy of a technology-based information and coaching/support program on pain and symptoms in Asian American survivors of breast cancer
Im, E.
Vol. 126 , pp. 670-680
132 views DOI
2019
alfabetizadoras y lectura: reflexiones sobre sus concepciones y prácticas
;Lais Fernanda Espósito Barbosa;Elianeth Dias Kanthack Hernandes
Vol. 6 , No. 15 , pp. 114-133
166 views DOI Abstract
42
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

41.9/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.7/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.